Identification of the ataxin-1 interaction network and its impact on spinocerebellar ataxia type 1
Abstract Background Spinocerebellar ataxia type 1 (SCA1) is a neurodegenerative disease caused by a polyglutamine expansion in the ataxin-1 protein. The pathogenic mechanism resulting in SCA1 is still unclear. Protein–protein interactions affect the function and stability of ataxin-1. Methods Wild-t...
Main Authors: | Jiu-Ming Chen, Shi-Kai Chen, Pei-Pei Jin, Shun-Chang Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-07-01
|
Series: | Human Genomics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40246-022-00404-0 |
Similar Items
-
Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: Removal of the CAG containing exon
by: Melvin M. Evers, et al.
Published: (2013-10-01) -
Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches
by: Luis C. Velázquez-Pérez, et al.
Published: (2017-09-01) -
Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation
by: An-Hsun Chou, et al.
Published: (2008-07-01) -
Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion
by: Anna Niewiadomska-Cimicka, et al.
Published: (2020-06-01) -
Polyglutamine-expanded ataxin-3 activates mitochondrial apoptotic pathway by upregulating Bax and downregulating Bcl-xL
by: An-Hsun Chou, et al.
Published: (2006-02-01)